Capital expenditure · 2020–2025

Cytek Biosciences capital expenditure

$4.1M+15.9% · FY2025

Cytek Biosciences (CTKB) reported $4.1M in capital expenditure for fiscal 2025, +15.9% year on year.

$1.5M2020$4.4M2021$9.7M2022$4.6M2023$3.5M2024$4.1M2025
Cytek Biosciences — Capital expenditure, 2020–2025
Fiscal yearCapital expenditureChangeFiling
FY20252025-12-31$4.1M+15.9%Open →
FY20242024-12-31$3.5M−24.2%Open →
FY20232023-12-31$4.6M−52.3%Open →
FY20222022-12-31$9.7M+123.4%Open →
FY20212021-12-31$4.4M+182.1%Open →
FY20202020-12-31$1.5M—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2020–2025 compound annual growth +21.4%

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Cytek Biosciences capital expenditure |url=https://companiesranked.com/en/company/cytek-biosciences/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Cytek Biosciences capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/cytek-biosciences/capital-expenditure

BibTeX

@misc{companiesranked-en-company-cytek-biosciences-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Cytek Biosciences capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/cytek-biosciences/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001628280-26-012352 · February 26, 2026

{{cite web |title=Cytek Biosciences capital expenditure — 10-K (0001628280-26-012352) |url=https://www.sec.gov/Archives/edgar/data/1831915/000162828026012352/ctkb-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Cytek Biosciences overview